Infinity Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“IPI-609 has demonstrated efficacy as a single agent in preclinical animal models of aggressive pancreatic and prostate cancer.” Read the following article
Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. [Source: MarketWatch]
Company Website: http://www.infi.com